Skip to main content
. 2023 Oct 11;41(12):3619–3627. doi: 10.1007/s00345-023-04648-w

Table 1.

Demographic characteristics and baseline data of two groups

NTFS-UAS group T-UAS group t/χ2 P value
Total number, (n) 102 112
Age (years), mean ± SD 47.69 ± 9.18 46.75 ± 11.87 0.648 0.517
Gender, n (%) 1.978 0.160
 Male 55 (53.9%) 71 (63.4%)
 Female 47 (46.1%) 41 (36.6%)
 BMI (kg/m2), mean ± SD 24.25 ± 2.97 23.54 ± 3.37 1.645 0.101
ASA score, n (%) 0.987 0.667
 I 12 (11.8%) 9 (8.0%)
 II 88 (86.3%) 101 (90.2%)
 III 2 (1.9%) 2 (1.8%)
Comorbidities, n (%) 1.841 0.616
 Hypertension 18 (17.6%) 19 (17.0%)
 Diabetes mellitus 8 (7.8%) 5 (4.5%)
 Renal insufficiency 10 (9.8%) 8 (7.1%)
Operative side, n (%) 0.956 0.328
 Left 46 (45.1%) 58 (51.8%)
 Right 56 (54.9%) 54 (48.2%)
History of surgery on ipsilateral side, n (%) 1.256 0.764
 RIRS 9 (8.8%) 13 (11.6%)
 PCNL 8 (7.8%) 12 (10.7%)
 Open surgery 3 (2.9%) 4 (3.6%)
Midstream urine culture, n (%) 1.843 0.175
 Positive 26 (25.5%) 20 (17.9%)
 Negative 76 (74.5%) 92 (82.1%)
 Renal stone size (range); mm, mean ± SD 18.47 ± 4.67 18.20 ± 4.46 0.440 0.661
 Renal stone hardness (HU), mean ± SD 1061.67 ± 272.54 1096.38 ± 240.94 0.989 0.324
Stone location, n (%) 0.417 0.981
 Pelvis 41 (40.2%) 43 (38.4%)
 Upper calyx 10 (9.8%) 9 (8.0%)
 Middle calyx 9 (8.8%) 11 (9.8%)
 Lower calyx 12 (11.8%) 15 (13.4%)
 Multiple calyxes 30 (29.4%) 34 (30.4%)
Hydronephrosis, n (%) 3.530 0.314
 No 27 (26.5%) 24 (21.4%)
 Mild 47 (46.1%) 57 (50.9%)
 Moderate 22 (21.6%) 29 (25.9%)
 Gross 6 (5.9%) 2 (1.8%)
Preoperative ureteral stent placement, n (%) 0.213 0.644
 Yes 46 (45.1%) 47 (42.0%)
 No 56 (54.9%) 65 (58.0%)

NTFS-UAS novel tip-flexible suctioning ureteral access sheath, T-UAS traditional ureteral access sheath, SD standard deviation, BMI body mass index, ASA American Society of Anesthesiologists, RIRS retrograde intrarenal surgery, PCNL percutaneous nephrolithotomy, HU Hounsfield Unit